We are live on ! Find out more
CLYM

Climb Bio
CLYM

76 hedge funds and large institutions have $63.4M invested in Climb Bio in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 23

5% less funds holding

Funds holding: 80 → 76 (-4)

5.9% less ownership

Funds ownership: 82.87% → 76.97% (-5.9%)

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

37% less capital invested

Capital invested by funds: $100M → $63.4M (-$36.9M)

Holders
76
Holders Change
-4
Holders Change %
-5%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
23
Reduced
23
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$2.96M
2
CF
Cantor Fitzgerald
New York
+$2.19M
3
AAA
Affinity Asset Advisors
New York
+$1.62M
4
TCM
Tang Capital Management
California
+$1.62M
5
PLC
Peapod Lane Capital
New York
+$898K

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$5.72M
2
SB
Samsara BioCapital
California
-$4.7M
3
BCM
Boxer Capital Management
California
-$3.99M
4
Bank of America
Bank of America
North Carolina
-$1.62M
5
ABG
Ally Bridge Group
New York
-$1.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
Mariner
51
Mariner
Kansas
$21K -$132K -81,102 -83%
VPIM
52
Vanguard Personalized Indexing Management
California
$18.6K +$24.7K +15,225 New
CPIG
53
Chicago Partners Investment Group
Illinois
$18.1K -$10.9K -6,737 -31%
SG Americas Securities
54
SG Americas Securities
New York
$18K -$26.2K -16,177 -52%
CF
55
Corebridge Financial
Texas
$17.6K -$345 -213 -1%
CUAMC
56
China Universal Asset Management Company
China
$16.4K -$1.25K -770 -5%
New York State Common Retirement Fund
57
New York State Common Retirement Fund
New York
$12.8K – – –
TRCT
58
Tower Research Capital (TRC)
New York
$9.92K +$4.11K +2,536 +45%
PFSRSONJ
59
Police & Firemen's Retirement System of New Jersey
New Jersey
$7.16K – – –
BNP Paribas Financial Markets
60
BNP Paribas Financial Markets
France
$7.03K -$61.8K -38,130 -87%
SO
61
STRS Ohio
Ohio
$6.47K – – –
Royal Bank of Canada
62
Royal Bank of Canada
Ontario, Canada
$6K -$156 -96 -2%
AIP
63
Ameritas Investment Partners
Nebraska
$3.64K – – –
Fidelity Investments
64
Fidelity Investments
Massachusetts
$3.23K -$17.7K -10,913 -80%
Legal & General Group
65
Legal & General Group
United Kingdom
$3.16K – – –
Mirae Asset Global Investments
66
Mirae Asset Global Investments
South Korea
$2.88K +$15 +9 +0.4%
California State Teachers Retirement System (CalSTRS)
67
California State Teachers Retirement System (CalSTRS)
California
$2.65K – – –
MCP
68
Militia Capital Partners
Nevada
$2.07K – – –
Carson Wealth (CWM LLC)
69
Carson Wealth (CWM LLC)
Nebraska
$2K +$3.22K +1,984 +9,018%
GFM
70
GF Fund Management
China
$1.97K +$331 +204 +14%
AB
71
Amalgamated Bank
New York
$1K +$1.24K +764 +303%
SCM
72
Sterling Capital Management
North Carolina
$584 -$749 -462 -49%
CCM
73
Coldstream Capital Management
Washington
$410 +$545 +336 New
TWD
74
True Wealth Design
Ohio
$15 +$19 +12 New
SS
75
SBI Securities
Japan
$12 – – –
1 2
3
4

CLYM Hedge Fund Activity: Q1 2025 in Review

76 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Climb Bio (CLYM) for Q1 2025, worth a combined $63.4M — down 37% from $100M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CLYM and 10 opened new positions — a net loss of 4 holders — while 23 trimmed existing stakes and 23 added.

The largest buyer was Citigroup, adding an estimated $2.96M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $5.72M sold.

  • 76 institutional investors held Climb Bio (CLYM) as of Q1 2025, down from 80 in Q4 2024.
  • Funds reported $63.4M of Climb Bio stock for Q1 2025, down 37% quarter-over-quarter.
  • 10 funds opened new Climb Bio positions in Q1 2025 and 14 closed out, a net change of -4 holders.
  • The largest Climb Bio buyer in Q1 2025 was Citigroup, an estimated $2.96M added.
  • The largest Climb Bio seller in Q1 2025 was Janus Henderson Group, an estimated $5.72M sold.

Based on aggregated 13F filings for Q1 2025.